Search - tctmd.com

Displaying 241 - 260 of 580

Sort: Relevancy | Date

News Daily News

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Shelley Wood

February 23, 2016

News Daily News

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

Shelley Wood

February 23, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Daily News

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Michael O'Riordan

February 08, 2016

News Daily News

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Michael O'Riordan

February 08, 2016

News Daily News

Se Observan Cambios Subclínicos en la Hemodinámica Valvular en Pacientes TAVR

Michael O'Riordan

February 08, 2016

News Daily News

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

L.A. McKeown

February 07, 2016

News Daily News

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

L.A. McKeown

February 07, 2016

News Daily News

TAVR 后的谵妄未得到充分认识并且被过分低估，导致患者处于危险中

Shelley Wood

January 20, 2016

News Daily News

No se da Importancia Debida a los Delirios Post-TAVR Poniendo en Peligro a los Pacientes

Shelley Wood

January 20, 2016

News Daily News

Delirium Is Under-recognized and Underestimated Following TAVR, Putting Patients in Peril

Shelley Wood

January 20, 2016

News Daily News

TAVR 后房颤尤其是新发房颤与死亡风险升高有关

Michael O'Riordan

January 18, 2016

News Daily News

El Diagnóstico de FA Post-TAVR sobre todo de Nueva Aparición se asocia a un Mayor Riesgo de Mortalidad

Michael O'Riordan

January 18, 2016

News Daily News

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Michael O'Riordan

January 18, 2016

News Daily News

FDA Grants Go-Ahead for Low-Risk TAVR Study

Shelley Wood

January 14, 2016

News Daily News

Sapien 是经导管肺动脉瓣置换的“可行、持久”方案

Michael O'Riordan

December 27, 2015

News Daily News

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

Michael O'Riordan

December 27, 2015

News Daily News

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Michael O'Riordan

December 27, 2015

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

德国数据显示 TAVR 的出现对临床实践模式产生影响

L.A. McKeown

December 16, 2015

Advertisement

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Se Observan Cambios Subclínicos en la Hemodinámica Valvular en Pacientes TAVR

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

TAVR 后的谵妄未得到充分认识并且被过分低估，导致患者处于危险中

No se da Importancia Debida a los Delirios Post-TAVR Poniendo en Peligro a los Pacientes

Delirium Is Under-recognized and Underestimated Following TAVR, Putting Patients in Peril

TAVR 后房颤尤其是新发房颤与死亡风险升高有关

El Diagnóstico de FA Post-TAVR sobre todo de Nueva Aparición se asocia a un Mayor Riesgo de Mortalidad

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

FDA Grants Go-Ahead for Low-Risk TAVR Study

Sapien 是经导管肺动脉瓣置换的“可行、持久”方案

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

德国数据显示 TAVR 的出现对临床实践模式产生影响

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content